Related references
Note: Only part of the references are listed.Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Alicia T. Widge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Enterovirus and Encephalitis
Bo-Shiun Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines
Dianliang Lei et al.
VACCINE (2020)
Recent Progress on the Versatility of Virus-Like Particles
Ciying Qian et al.
VACCINES (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
Suhaili Mustafa et al.
VACCINES (2020)
Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan
Li-Min Huang et al.
VACCINE (2019)
Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
Xiaoli Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate
Yi-Hsuan Tsai et al.
JOURNAL OF VIROLOGY (2019)
Enterovirus A71: virulence, antigenicity, and genetic evolution over the years
Sheng-Wen Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
Jiratchaya Puenpa et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Antivirals and vaccines for Enterovirus A71
Jing-Yi Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Enterovirus A71 neurologic complications and long-term sequelae
Luan-Yin Chang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
Pinn Tsin Isabel Yee et al.
SCIENTIFIC REPORTS (2019)
Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71
Xi Wang et al.
ARCHIVES OF VIROLOGY (2018)
VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection
Ken Fujii et al.
JOURNAL OF VIROLOGY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence
Ching-Kun Chang et al.
SCIENTIFIC REPORTS (2018)
Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
Yuemei Hu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity
Wei Zhang et al.
EMERGING MICROBES & INFECTIONS (2018)
Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development
Yu-Kang Chang et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2018)
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study
Mingwei Wei et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Characterization of human enterovirus71 virus-like particles used for vaccine antigens
Dandan Zhao et al.
PLOS ONE (2017)
An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice
Hyun Ju In et al.
PLOS ONE (2017)
Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice
Chunling Huo et al.
VACCINE (2017)
Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs
O. S. Nikonov et al.
BIOCHEMISTRY-MOSCOW (2017)
Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine
Yang Zhou et al.
EXPERT REVIEW OF VACCINES (2016)
EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)
Qun-ying Mao et al.
EXPERT REVIEW OF VACCINES (2016)
Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients
Kam Leng Aw-Yong et al.
PLOS ONE (2016)
Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges
Qin Yan et al.
VACCINE (2016)
Update on hand-foot-and-mouth disease
Daniel Ventarola et al.
CLINICS IN DERMATOLOGY (2015)
Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity
Michiko Hyakumura et al.
JOURNAL OF VIROLOGY (2015)
High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice
Chao Zhang et al.
VACCINE (2015)
A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice
Liping Jiang et al.
VACCINE (2015)
Recombinant Adeno-Vaccine Expressing Enterovirus 71-Like Particles against Hand, Foot, and Mouth Disease
Yueh-Liang Tsou et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Review of Enterovirus 71 Vaccines
Pele Chong et al.
CLINICAL INFECTIOUS DISEASES (2015)
Characterization of the Enterovirus 71 VP1 Protein as a Vaccine Candidate
Shi-Li Zhou et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Update on the development of enterovirus 71 vaccines
Yu-An Kung et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Attenuation of Human Enterovirus 71 High-Replication-Fidelity Variants in AG129 Mice
Tao Meng et al.
JOURNAL OF VIROLOGY (2014)
An Inactivated Enterovirus 71 Vaccine in Healthy Children
Rongcheng Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China
Fengcai Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop
Longfa Xu et al.
THERANOSTICS (2014)
Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine
Xue Han et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Ribavirin-Resistant Mutants of Human Enterovirus 71 Express a High Replication Fidelity Phenotype during Growth in Cell Culture
Sara Sadeghipour et al.
JOURNAL OF VIROLOGY (2013)
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Feng-Cai Zhu et al.
LANCET (2013)
Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers
Ai-Hsiang Chou et al.
PLOS ONE (2013)
Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
Hao-Yang Li et al.
VACCINE (2013)
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
Aristine Cheng et al.
VACCINE (2013)
Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction
Yorihiro Nishimura et al.
PLOS PATHOGENS (2013)
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71
Xiangxi Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
Ai-Hsiang Chou et al.
PLOS ONE (2012)
Selection and characterization of vaccine strain for Enterovirus 71 vaccine development
Jui-Yuan Chang et al.
VACCINE (2012)
Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles
Yu-Li Lin et al.
VACCINE (2012)
Production of EV71 vaccine candidates
Pele Chong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Host Factors in Enterovirus 71 Replication
Shin-Ru Shih et al.
JOURNAL OF VIROLOGY (2011)
Display of VP1 on the Surface of Baculovirus and Its Immunogenicity against Heterologous Human Enterovirus 71 Strains in Mice
Tao Meng et al.
PLOS ONE (2011)
A Single Nucleotide in Stem Loop II of 5′-Untranslated Region Contributes to Virulence of Enterovirus 71 in Mice
Ming-Te Yeh et al.
PLOS ONE (2011)
Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection
Emily Jane Bek et al.
VACCINE (2011)
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
Zhenglun Liang et al.
VACCINE (2011)
Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys
Chenghong Dong et al.
VACCINE (2011)
Antibody dependent enhancement infection of Enterovirus 71 in vitro and in vivo
Jian-Feng Han et al.
VIROLOGY JOURNAL (2011)
Clinical features, diagnosis, and management of enterovirus 71
Mong How Ooi et al.
LANCET NEUROLOGY (2010)
Combined peptides of human enterovirus 71 protect against virus infection in mice
Jiang Ning Liu et al.
VACCINE (2010)
Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide
Damian Guang Wei Foo et al.
MICROBES AND INFECTION (2007)
An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys
Minetaro Arita et al.
JOURNAL OF VIROLOGY (2007)
Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides
Damian Guang et al.
VIRUS RESEARCH (2007)
Expression, purification and characterization of enterovirus-71 virus-like particles
Yao-Chi Chung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Polio eradication, cessation of vaccination and re-emergence of disease
PD Minor
NATURE REVIEWS MICROBIOLOGY (2004)
Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells
YC Hu et al.
BIOTECHNOLOGY LETTERS (2003)
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization
BK Chakrabarti et al.
JOURNAL OF VIROLOGY (2002)
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
CN Wu et al.
VACCINE (2001)
Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites
A Fournillier et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
